Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice

Fig. 5

Overexpression of Sema3A in oral cancer inhibits VEGFR2 phosphorylation, and reduces the phosphorylation levels of its downstream genes Src and FAK. a lane1, VEGF-stimulating SSC-9 without Sema3A overexpression; lane2: VEGF-stimulating SSC-9 with Sema3A overexpression. b Lane 1: oral cancer treated with LentiEGFP; Lane 2: oral cancer treated with LentiSema3A-EGFP. The experiment was repeated 3 times

Back to article page